75439--3/31/2009--CytoCore_Inc

related topics
{stock, price, share}
{product, market, service}
{regulation, government, change}
{stock, price, operating}
{product, liability, claim}
{property, intellectual, protect}
{personnel, key, retain}
{operation, international, foreign}
{system, service, information}
{acquisition, growth, future}
{competitive, industry, competition}
{customer, product, revenue}
We currently depend on the sale of a single product and product line. Our future success will depend on our ability to develop new products and respond to technological changes in the markets in which we compete. Our products are subject to government regulation and they may not receive necessary government approvals. Changes in third-party reimbursement may negatively affect us. Our international operations expose us to additional risks. We may not be able to compete with companies that are larger and have more resources. We may not be able to market our products. The accuracy, performance and cost of our products are critical to our business and reputation, and we are subject to product liability. We may not be able to adequately protect our intellectual property. We may not be able to maintain effective product distribution channels. Our quarterly operating results may fluctuate and our future revenues and profitability are uncertain. The loss of existing key management and technical personnel or the inability to attract new hires could have a detrimental effect on the Company. We may need to expand our operations and we may not effectively manage any future growth. Risks Related to Our Common Stock There is a limited market for penny stocks such as our common stock. The historically volatile market price of our common stock may affect the value of our stockholders investments. Our common stock is unlikely to produce dividend income for the foreseeable future. Our common stock is subject to dilution, and an investor s ownership interest and related value may decline.

Full 10-K form ▸

related documents
896429--9/28/2006--USA_TECHNOLOGIES_INC
1371128--3/25/2008--BioSolar_Inc
822418--3/5/2008--BIO_IMAGING_TECHNOLOGIES_INC
822418--3/29/2007--BIO_IMAGING_TECHNOLOGIES_INC
1097792--3/27/2009--MEDIANET_GROUP_TECHNOLOGIES_INC
1011432--3/31/2010--AUXILIO_INC
1080627--7/9/2008--GOLDEN_KEY_INTERNATIONAL_INC
81350--4/16/2009--BLINK_LOGIC_INC.
1042610--10/13/2010--TRB_SYSTEMS_INTERNATIONAL_INC
352998--3/31/2009--IGI_INC
1035092--3/16/2007--SHORE_BANCSHARES_INC
1089473--3/16/2006--VENTIV_HEALTH_INC
1089473--2/28/2007--INVENTIV_HEALTH_INC
769592--6/29/2007--MOBILEPRO_CORP
1088034--3/27/2008--PAYMENT_DATA_SYSTEMS_INC
1017526--9/28/2007--ACE_COMM_CORP
1088034--3/31/2009--PAYMENT_DATA_SYSTEMS_INC
351017--3/27/2008--AUTOINFO_INC
351017--3/23/2009--AUTOINFO_INC
1079028--11/26/2008--VARIAN_INC
832488--9/30/2008--Aftersoft_Group
1323639--3/31/2008--180_Connect_Inc.
822418--3/5/2009--BIO_IMAGING_TECHNOLOGIES_INC
1372507--4/15/2009--RAVEN_BIOFUELS_INTERNATIONAL_CORP
779956--4/30/2007--FASTFUNDS_FINANCIAL_CORP
1144225--4/12/2010--instaCare_Corp.
1144225--5/18/2009--instaCare_Corp.
1292026--3/31/2010--Odimo_INC
790071--4/2/2007--ARISTOTLE_CORP
826253--6/15/2009--AURA_SYSTEMS_INC